Who owns SEEHRA JASBIR?

No ownership or control links for SEEHRA JASBIR are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is SEEHRA JASBIR's risk level?

WhiteIntel flags SEEHRA JASBIR as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does SEEHRA JASBIR appear across sources?

SEEHRA JASBIR is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Legal entityLow

SEEHRA JASBIR

Name: SEEHRA JASBIR — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, SEEHRA JASBIR, Company, US

SEEHRA JASBIR — US company (sec:0001732369). 3 holdings. Every claim linked to its source.

SEC 0001732369CompanyUS

Ownership graph Export .md

JSON / MCPsample

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

Holdings / subsidiaries

SEEHRA JASBIR
- Keros Therapeutics, Inc.· director· via SEC EDGAR
- Eloxx Pharmaceuticals, Inc.· director· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for SEEHRA JASBIR — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of SEEHRA JASBIR is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on SEEHRA JASBIR is behind a paywall — everything we hold on this subject is already on this page.

/02

People & control

2 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
Eloxx Pharmaceuticals, Inc.
Also holds roles at 82 other companies
- Aggarwal Sumitdirector
- Rubin Steven Ddirector
- Androski Lindsaydirector
●
Keros Therapeutics, Inc.
Also holds roles at 37 other companies
- CHYUNG YUNG H.officer
- Regnante Keithofficer
- Rovaldi Christopherofficer

2 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns SEEHRA JASBIR?: No ownership or control links for SEEHRA JASBIR are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is SEEHRA JASBIR's risk level?: WhiteIntel flags SEEHRA JASBIR as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does SEEHRA JASBIR appear across sources?: SEEHRA JASBIR is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on SEEHRA JASBIR. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…

Is this your company?

Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for SEEHRA JASBIR — nothing is disclosed before that.

Claim this record